Anavex Life Sciences Corp (AVXL)

[pcguy]

The problem I see in this case is that they collected data the for a method that was not defined in the trial design. If they intended to conduct the trial in this manner, they should have updated the trial information before the fact. Data is data, but image is perception. This is the problem every turn with Anavex. There seems to never be a straight answer up front, so regardless of how good the data may be, there is always the perception that the company is not being totally forthcoming. Get someone in there to pull thier head out of you know where so the alzheimers trial isn't screwed up too.